FBIO — Fortress Biotech Balance Sheet
0.000.00%
Last trade - 00:00
- $44.94m
- $6.28m
- $84.51m
- 23
- 38
- 37
- 24
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 137 | 233 | 306 | 178 | 80.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.4 | 24.7 | 23.8 | 28.3 | 15.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 156 | 266 | 346 | 230 | 117 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 33.9 | 32.4 | 34.1 | 33 | 23.5 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 226 | 333 | 397 | 294 | 168 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 45.6 | 51.8 | 101 | 128 | 84.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 200 | 233 | 288 | 253 | 145 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 26.2 | 100 | 109 | 41.7 | 22.5 |
Total Liabilities & Shareholders' Equity | 226 | 333 | 397 | 294 | 168 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |